Maven Clinic Announces New Clinical Research and Investments in Innovation to Advance Industry-Leading Care Model for Women’s and Family Health
New clinical research highlights the power of digital health in reducing unnecessary C-sections and addressing social determinants of health
Maven Clinic, the world’s largest virtual clinic for women’s and family health, today announced several clinical innovation milestones, including publishing results from two new peer-reviewed studies and appointing its next Visiting Scientist to deepen insights into perinatal mental health. These advancements demonstrate how Maven is redesigning the care model for women’s and family health, centering the needs of members while driving down healthcare spend for its partners.
“To deliver on its promise, digital health must provide more than an improved user experience — it has to impact the generational problems of healthcare, including inequity and high costs,” said Kate Ryder, founder and CEO of Maven Clinic. “Maven’s platform has a strong clinical foundation that is delivering industry-leading results for our partners on the issues that matter most.”
Maven’s latest research reinforces the effectiveness of the company’s care model to detect social determinants of health and to lower C-section rates, among other clinical outcomes. The research includes:
Maven’s family-building programs reduce costs for employers and health plans, while bringing together clinical, emotional and financial support to improve health and business outcomes for its members. The company’s care model has demonstrated that it has lowered C-section rates by up to 20%, reduced NICU (neonatal intensive care unit) admissions by up to 28%, and helped as many as 25% of its fertility members to achieve pregnancy without assisted reproductive technology. Maven’s ROI calculation methodology for its maternity and fertility programs was independently reviewed and validated by Milliman, Inc., as described in the associated reports (maternity, fertility).
“Digital care models have as much potential to impact people’s health as drugs or devices, and should be developed with a high standard of scientific rigor,” said Dr. Neel Shah, Chief Medical Officer of Maven Clinic. “Maven has built evidence-based programs that close critical gaps in access to services while measuring and publicly reporting our work.”
In addition to announcing new research, Maven has welcomed a new clinician innovator, Dr. Constance Guille, Professor in the Department of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology at Medical University of South Carolina, as its second Visiting Scientist. In this role, Dr. Guille will bring her expertise as a reproductive psychiatrist to help advance Maven’s clinical research roadmap and provide strategic input on care model design, with a focus on mental health.
“Having seen the devastating effects of unrecognized and untreated maternal mental health disorders, I believe there is a tremendous need and promise for using digital health to integrate patient-centered maternal behavioral health treatment into routine prenatal care,” said Dr. Guille. “I am excited to share my insights with Maven to further advance the company’s maternal mental health care model.”
About Maven Clinic
Maven is the largest virtual clinic for women’s and family health, offering continuous, holistic care for fertility and family building through maternity, parenting, pediatrics and menopause. Maven’s award-winning digital programs are trusted by leading employers and health plans to reduce costs and drive better maternal health outcomes, as well as enhance DE&I in benefits programs. Founded in 2014 by CEO Kate Ryder, Maven has been recognized as Fast Company’s #1 Most Innovative Health Company and has 15 million lives under management. Maven has raised $300 million in funding from leading investors including General Catalyst, Sequoia, Oak HC/FT, Dragoneer Investment Group and Lux Capital. To learn more about Maven, visit us at mavenclinic.com.